Effects of Different Moderate-intensity Exercise Methods on Health in the Elderly
NCT ID: NCT05207501
Last Updated: 2023-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2022-09-01
2023-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* In hypoxic conditions (i.e. when the amount of oxygen in the air is decreased as at altitude).
* With intermittent blood flow restriction (by inflating pneumatic cuffs around the thighs to a pressure that restricts blood flow). This equipment is harmless.
* With eccentric training (resisting against the movement of the pedal of a bicycle rather than pushing it).
The purpose of this study is then to evaluate whether moderate intensity intermittent training can induce similar or greater effects on cardiovascular health when combined with intermittent hypoxia, intermittent blood flow restriction or eccentric training.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly
NCT05048680
High Intensity Interval Training Versus Moderate Intensity Continuous Training in Frail Elderly
NCT07211334
Exploring How Exercise Frequency Impacts Muscle Resistance and Balance in Institutionalized Seniors
NCT07060729
Study of the Long-term Effects of Exercise on Heath Indicators in Older People
NCT01874132
Overcoming Inactivity in Older Adults: Impact on Vascular Homeostasis
NCT01212978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Interestingly, living at altitude seems to reduce some cardiovascular risks. In addition, the beneficial effects of physical training seem to be greater when performed under hypoxic conditions (i.e. when the amount of oxygen in the air is decreased as at altitude).
* Another interesting strategy for the elderly is intermittent blood flow restriction. This involves inflating pneumatic cuffs around the limb(s) to a pressure that blocks or restricts blood flow to the affected muscles, alternating with rest phases. It has been found that endurance training, combined with blood flow restriction, promotes the growth of new blood vessels, which could be particularly important for the prevention of cardiovascular disease in the elderly, which is unfortunately common.
* Eccentric training is currently emerging as a promising training strategy for the elderly. It consists of resisting the movement of the pedal of a bicycle rather than pushing it. It requires less energy effort than traditional exercise with the same workload. Eccentric training has been shown to improve older adults' body composition and muscle strength, thereby improving exercise capacity and quality of life.
These training strategies may be of interest for cardiovascular health in older adults. However, there are few data on their combined effects with exercise in the elderly and there is no consensus to favor one method over another.
The objective of this study is then to evaluate whether moderate-intensity intermittent training can induce similar or superior effects on health indicators when combined with intermittent hypoxia, partial vascular occlusion, or eccentric training.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moderate-intensity intermittent training (MIIT)
The MIIT will be conducted on a cycle ergometer (Lode Ex. calibur Sport Ergometer, Lode B.V., the Netherlands) in normoxia (FiO2 = \~ 21%). The participants will perform the MIIT starting with the ergometer resistance set to obtain the %HRmax set (\~75-80%) during 5 minutes and will rest 5 minutes after each interval of exercise. The HRmax will be considered as 200 - age.
Exercise
Participants will perform 3 times a week for 4 weeks a moderate intensity interval training.
MIIT during intermittent hypoxic exposure (IHYP + MIIT)
A normobaric hypoxic chamber (ATS Altitude Training, Sydney, Australia) will be used for this protocol. The chamber (2.4 m x 5 m x 2.5 m) allows, via a filter and compressor system, to extract oxygen molecules and to reduce the fraction of inspired oxygen (FiO2) with no modification of the barometric pressure.
Exercise
Participants will perform 3 times a week for 4 weeks a moderate intensity interval training.
MIIT during intermittent blood flow restriction (IBFR + MIIT)
The IBFR + MIIT protocol will be performed while cycling in normoxia (FiO2 = \~ 21%). Elastic, pneumatic cuffs (BStrong, Park City, Utah, USA) will be administered as high as possible at the inguinal crease of the upper thigh and will be inflated during the cycling to the set pressure of 400 mmHg (except for the first training session, it will be of 250 mmHg to minimize soreness and to accustom patients to vascular occlusion training). The cuffs will be deflated at interval rest.
Exercise
Participants will perform 3 times a week for 4 weeks a moderate intensity interval training.
Moderate-intensity eccentric cycling (MIEC)
The MIEC will be conducted on a cycle ergometer (Excalibur, Lode, Groningen, The Nederlands) in normoxia (FiO2 = \~ 21%). The participants will be instructed to resist against the pedal movement (cadence set at 15 revolutions/min) to produce the required torque (set to obtain the 75-80%HRmax) indicated by visual feedback for 5 minutes and will rest 5 minutes after each interval of exercise. The HRmax will be considered as 200 - age. The HR responses will be monitored (Polar Electro Oy, Kempele, Finland).
Exercise
Participants will perform 3 times a week for 4 weeks a moderate intensity interval training.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Participants will perform 3 times a week for 4 weeks a moderate intensity interval training.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. not involved in regular physical activities for at least 6 months (i.e., doing no physical exercise over twice per week);
3. free of injuries as well as cardiovascular and respiratory disorders or central nervous system disease or receiving β-blocker medication;
4. not using dietary supplements, smoking or drugs which interfere with the measurements;
5. not using creatine supplementation, anabolic steroids, drugs, or medication with potential effects on physical performance;
6. to have body index mass between 20 and 30 kg/m²;
7. not to live above 800m of altitude;
8. to be vaccinated against COVID-19 and to have no symptoms (fever, cough, fatigue, loss of smell or taste);
9. able to complete all sessions;
10. able to give consent.
65 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lausanne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gregoire Millet
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Lausanne
Lausanne, Canton of Vaud, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-02135
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.